Internal Mammary Sentinel Lymph Nodes in Breast Cancer - Effects on Disease Prognosis and Therapeutic Protocols - A Case Report

Authors

  • Sinisa Stojanoski Institute of Patophysiology and Nuclear medicine "Acad Isak S. Tadzer", Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
  • Nevena Ristevska Institute of Patophysiology and Nuclear medicine "Acad Isak S. Tadzer", Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
  • Daniela Pop-Gjorcheva Institute of Patophysiology and Nuclear medicine "Acad Isak S. Tadzer", Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
  • Borce Antevski University Clinic of Thoraco-Vascular Surgery, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
  • Gordana Petrushevska Institute of Pathology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje

DOI:

https://doi.org/10.3889/oamjms.2015.025

Keywords:

sentinel lymph nodes (SLN), internal mammary lymph nodes, gamma detection probe, metilen blue dye, breast cancer

Abstract

BACKGROUND: The main prognostic factor in early staged breast cancer is the axillary lymph node metastatic affection. Sentinel lymph node biopsy, as a staging modality, significantly decreases surgical morbidity. The status of internal mammary lymph nodes gains an increased predictive role in grading breast carcinomas and modulation of postoperative therapeutic protocols. If positive, almost always are associated with worse disease outcome. Nevertheless, the clinical significance of internal mammary lymph node micrometastases has not been up to date precisely defined. 

AIM: To present a case of female patient clinically diagnosed as T1, N0, M0 (clinical TNM) ductal breast carcinoma with scintigraphic detection of internal mammary and axillary sentinel lymph nodes.

METHODS:  Dual method of scintigraphic sentinel lymph node detection using 99mTc-SENTI-SCINT and blue dye injection, intraoperative gamma probe detection, radioguided surgery and intraoperative ex tempore biopsy were used.

CASE REPORT: We present a case of clinically T1, N0, M0 ductal breast cancer with scintigraphic detection of internal mammary and axillary sentinel lymph nodes. Intraoperative ex tempore biopsy revealed micrometastases in the internal mammary node and no metastatic involvement of the axillary sentinel lymph node.

CONCLUSION: Detection of internal mammary lymph node metastases improves N (nodal) grading of breast cancer by selecting a high risk subgroup of patients that require adjuvant hormone therapy, chemotherapy and/or radiotherapy.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Veronesi U, Paganelli GT, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864–1867. DOI: https://doi.org/10.1016/S0140-6736(97)01004-0

Kuehn T, Bembenek A, Decker T, Munz DL, Sautter-Bihl ML, Untch M, Wallwiener D. Consensus Committee of the German Society of Senology. Cancer. 2005;103:451–461. DOI: https://doi.org/10.1002/cncr.20786

Intra M, Garcia-Etienne CA, Renne G, Trifro G, Rotmensz N, Gentillini OD, Galimberti V, Sagona A, Mattar D, Sangalli C, Gatti G, Luini A, Veronesi U. When sentinel lymph node is intramammary. Ann Surg Oncol. 2008;15:1304–1308.

Hogan BV, Peter MB, Shenoy H, Horgan K, Shaaban A. Intramammary lymph node metastasis predicts poorer survival in breast cancer patients. Surg Oncol. 2010;19:11–16. DOI: https://doi.org/10.1016/j.suronc.2008.12.009

Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Ames FC, Babiera GV. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast cancer. Cancer. 2004;101:1330–1337. DOI: https://doi.org/10.1002/cncr.20515

Cody HS, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol. 1995; 2: 32–37. DOI: https://doi.org/10.1007/BF02303699

Caceres E. Incidence of metastasis in the internal mammary chain in operable cancer of the breast. Surg Gynaecol Obstet. 1959; 108: 715–720.

Lacour J, Le M, Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten-year results of an international cooperative trial in breast cancer. Cancer. 1983; 51: 1941–1943. DOI: https://doi.org/10.1002/1097-0142(19830515)51:10<1941::AID-CNCR2820511032>3.0.CO;2-T

Donegan WL. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer. 1977; 39: 533–538. DOI: https://doi.org/10.1002/1097-0142(197702)39:2<533::AID-CNCR2820390222>3.0.CO;2-V

Morrow M, Foster RS, Jr. Staging of breast cancer: a new rationale for internal mammary node biopsy. Arch Surg. 1981; 116: 748–751. DOI: https://doi.org/10.1001/archsurg.1981.01380180012003

Veronesi U, Cascinelli N, Bufalino R, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg. 1983; 198: 681–684. DOI: https://doi.org/10.1097/00000658-198312000-00002

Guth AA, Mercado C, Roses DF, Hiotis K, Skinner K, Diflo T. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node? Am J Surg. 2006;192:502–505. DOI: https://doi.org/10.1016/j.amjsurg.2006.05.011

van der Ent FW, Kengen RA, van der Pol HA, Povel JA, Stroeken HJ, Hoofwijk AG. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg. 2001;234(1):79-84. DOI: https://doi.org/10.1097/00000658-200107000-00012

Intra M, Garcia-Etienne CA, Renne G, Trifro G, Rotmensz N, Gentillini OD, Galimberti V, Sagona A, Mattar D, Sangalli C, Gatti G, Luini A, Veronesi U. When sentinel lymph node is intramammary. Ann Surg Oncol. 2008;15:1304–1308. DOI: https://doi.org/10.1245/s10434-007-9720-1

Kijima Y, Yohinaka H, Uenosono Y, Funasako Y, Ehi K, Yanagita S, Arima H, Kozono T, Arigami T, Natsugoe S, Aikou T. Intramammary sentinel lymph node in patients with breast cancer: Report of four cases. Surg Today. 2008;38:536–540. DOI: https://doi.org/10.1007/s00595-007-3660-z

Mathelin C, Tomasetto C, Rio MC, Chenard MP, Brettes JP, Guyonnet JL. Improvement in intramammary sentinel lymph node removal using a novel prototype hand held probe during breast conservative surgery. Breast Cancer Res Treat. 2005;89:305–308. DOI: https://doi.org/10.1007/s10549-004-2128-8

Tytle I, Hayes A, Kissin M. Intramammary sentinel lymph nodes in early breast cancer: can we find them and do they matter? Eur J Surg Oncol. 2003;29:6–8. DOI: https://doi.org/10.1053/ejso.2002.1336

Gajdos C, Bleiweiss IJ, Drossman S, Tartter PI. Breast cancer in an intramammary sentinel node. Breast J. 2001;7:260–262. DOI: https://doi.org/10.1046/j.1524-4741.2001.98106.x

Vijan SS, Hamilton S, Chen B, Reynolds C, Boughey JC, Degnim AC. Intramammary lymph nodes: Patterns of discovery and clinical significance. Surgery. 2009;145:495–499. DOI: https://doi.org/10.1016/j.surg.2009.01.015

Cox CE, Cox JM, Ramos D, Meade TL. Intramammary sentinel lymph nodes: what is the clinical significance? Ann Surg Oncol. 2008;15:1273–1274. DOI: https://doi.org/10.1245/s10434-007-9769-x

Published

2015-02-16

How to Cite

1.
Stojanoski S, Ristevska N, Pop-Gjorcheva D, Antevski B, Petrushevska G. Internal Mammary Sentinel Lymph Nodes in Breast Cancer - Effects on Disease Prognosis and Therapeutic Protocols - A Case Report. Open Access Maced J Med Sci [Internet]. 2015 Feb. 16 [cited 2024 Mar. 28];3(1):139-42. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2015.025

Issue

Section

C- Case Reports

Most read articles by the same author(s)

1 2 > >>